Share this article

The World Health Organization (WHO)’s Covid-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) have signed a licencing agreement for Spanish National Research Council’s (CSIC) Covid-19 serological antibody technology. The technology helps identify the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine. The agreement is expected to expedite the production and commercialisation of CSIC’s Covid-19 serological test worldwide and marks the first transparent, global, non-exclusive licence for a COVID-19 health tool, and the first test licence signed by MPP and included in the WHO Pool.

South Korean molecular diagnostics firm Seegene has announced it will introduce diagnostic tests in a move to better prepare for a potential increase in Covid-19 and influenza cases during the winter. The tests will be capable of identifying 22 targets including three Covid-19 genes in a single tube. This was announced alongside Seegene’s results for the third quarter of this year. The company reported sales revenue of KRW305.3bn ($260m) in the three-month period to 30 September 2021. The figure represents a 1% increase on a QoQ basis.

Vivera has introduced an AI software solution called LabPort to streamline the Covid-19 diagnostic testing process. The solution was created to enable immediate results reporting for diagnostic testing even in high-volume, field-based testing environments. It was first deployed in July 2021 and has been used to manage the testing process for more than 60,000 EUA-authorised rapid antigen and lab-based RT-PCR tests for major events.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData